Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Facial botulinum toxin A exposure and postoperative outcomes after mandibular third molar surgery
TCTR20260826006Not yet recruiting
- Sponsor
- Faculty of Dentistry, Chiang Mai University
- Start
- Nov 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of botulinum toxin type A (2 arms), sponsored by Faculty of Dentistry, Chiang Mai University. Primary endpoints: Salivary interleukin-6 level and Salivary tumor necrosis factor-alpha level. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
botulinum toxin type A
Beyond the preview
Go deeper on TCTR20260826006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260826006.